July 21, 2026

Member2Member: Where expertise meets the community

Member2Member: Where expertise meets the community

Every company in the bioRN network has a story to tell. More importantly, every company has knowledge that can help others move faster, avoid mistakes and spark new collaborations.

That is the idea behind bioRN’s Member2Member series.

Instead of traditional company presentations, Member2Member opens the doors to our member organisations and puts their expertise centre stage. Each session focuses on practical challenges, scientific insights and questions submitted by the bioRN community, creating conversations that remain valuable long after the live event has ended.

Our latest session took us to Cytion at LAB22 in Heidelberg.

Together with Henri Schwegler and Jannis Steinmann, we explored one of the foundations of biomedical research: reliable cell culture.

Following a behind-the-scenes tour of Cytion’s laboratories, the discussion addressed questions submitted by researchers from academia, biotech and industry, including:

  • Why does cell confluency matter for reproducible experiments?
  • How do you choose the right cell model?
  • What role does cell banking play in research quality?
  • When should scientists start thinking about process development and manufacturability?
  • How do GMP, raw materials and change control influence the journey from research to industrial application?

The discussion demonstrated that successful biomedical innovation depends not only on groundbreaking ideas, but also on robust biological models, reliable laboratory practice and a deep understanding of quality.

For bioRN, this is exactly what Member2Member is about: creating opportunities for members to share their expertise, learn from each other and strengthen the collaborative spirit of one of Europe’s leading life science ecosystems.

Watch the full interview with Cytion below and discover practical insights for researchers, biotech companies and industry professionals alike.

About bioRN M2M Member to Member:

Member2Member is bioRN’s interview series showcasing the expertise of our member organisations. Each session combines behind-the-scenes insights with questions submitted by the bioRN community, creating a growing library of practical knowledge for researchers, entrepreneurs and industry professionals. Find past M2M videos here

Our latest News

discover more
Member2Member: Where expertise meets the community

Member2Member: Where expertise meets the community

Every company in the bioRN network has a story to tell. More importantly, every company has knowledge that can help others move faster, avoid mistakes and spark new collaborations. That is the idea behind bioRN’s Member2Member series. Instead of traditional company presentations, Member2Member opens the doors to our member organisations and puts their expertise centre […]

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp